These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

383 related articles for article (PubMed ID: 20045994)

  • 21. Anthropometric measurements in childhood and prediction of cardiovascular risk factors in adulthood: Kaunas cardiovascular risk cohort study.
    Petkeviciene J; Klumbiene J; Kriaucioniene V; Raskiliene A; Sakyte E; Ceponiene I
    BMC Public Health; 2015 Mar; 15():218. PubMed ID: 25880559
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Clusters of metabolic risk factors predict cardiovascular events in hypertension with target-organ damage: the LIFE study.
    de Simone G; Olsen MH; Wachtell K; Hille DA; Dahlöf B; Ibsen H; Kjeldsen SE; Lyle PA; Devereux RB
    J Hum Hypertens; 2007 Aug; 21(8):625-32. PubMed ID: 17476291
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Impact of body mass index and the metabolic syndrome on the risk of cardiovascular disease and death in middle-aged men.
    Arnlöv J; Ingelsson E; Sundström J; Lind L
    Circulation; 2010 Jan; 121(2):230-6. PubMed ID: 20038741
    [TBL] [Abstract][Full Text] [Related]  

  • 24. The effect of increasing body mass index on cardio-metabolic risk and biomarkers of oxidative stress and inflammation in nascent metabolic syndrome.
    Pahwa R; Adams-Huet B; Jialal I
    J Diabetes Complications; 2017 May; 31(5):810-813. PubMed ID: 28285929
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Usefulness of New Criteria for Metabolic Syndrome Optimized for Prediction of Cardiovascular Diseases in Japanese.
    Yamazaki Y; Fujihara K; Sato T; Harada Yamada M; Yaguchi Y; Matsubayashi Y; Yamada T; Kodama S; Kato K; Shimano H; Sone H
    J Atheroscler Thromb; 2024 Apr; 31(4):382-395. PubMed ID: 37981330
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Associations of sarcopenic obesity with the metabolic syndrome and insulin resistance over five years in older men: The Concord Health and Ageing in Men Project.
    Scott D; Cumming R; Naganathan V; Blyth F; Le Couteur DG; Handelsman DJ; Seibel M; Waite LM; Hirani V
    Exp Gerontol; 2018 Jul; 108():99-105. PubMed ID: 29649572
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Relationship between Alcohol Intake and Risk Factors for Metabolic Syndrome in Men.
    Hirakawa M; Arase Y; Amakawa K; Ohmoto-Sekine Y; Ishihara M; Shiba M; Ogawa K; Okuda C; Jinno T; Kato H; Tsuji H; Hashimoto M; Yamamoto T; Arimoto S; Hara S
    Intern Med; 2015; 54(17):2139-45. PubMed ID: 26328637
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Metabolic Obesity Phenotypes and Risk of Breast Cancer in Postmenopausal Women.
    Kabat GC; Kim MY; Lee JS; Ho GY; Going SB; Beebe-Dimmer J; Manson JE; Chlebowski RT; Rohan TE
    Cancer Epidemiol Biomarkers Prev; 2017 Dec; 26(12):1730-1735. PubMed ID: 28939589
    [No Abstract]   [Full Text] [Related]  

  • 29. Irbesartan for the treatment of hypertension in patients with the metabolic syndrome: a sub analysis of the Treat to Target post authorization survey. Prospective observational, two armed study in 14,200 patients.
    Kintscher U; Bramlage P; Paar WD; Thoenes M; Unger T
    Cardiovasc Diabetol; 2007 Apr; 6():12. PubMed ID: 17407587
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Metabolic syndrome in Mediterranean women with polycystic ovary syndrome: when and how to predict its onset.
    Espinós-Gómez JJ; Rodriguez-Espinosa J; Ordóñez-Llanos J; Calaf-Alsina J
    Gynecol Endocrinol; 2012 Apr; 28(4):264-8. PubMed ID: 21962027
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Metabolic syndrome in adult patients with Prader-Willi syndrome.
    Grugni G; Crinò A; Bedogni G; Cappa M; Sartorio A; Corrias A; Di Candia S; Gargantini L; Iughetti L; Pagano C; Ragusa L; Salvatoni A; Spera S; Vettor R; Chiumello G; Brambilla P
    Nutr Metab Cardiovasc Dis; 2013 Nov; 23(11):1134-40. PubMed ID: 23220075
    [TBL] [Abstract][Full Text] [Related]  

  • 32. The relationship between metabolic syndrome and target organ damage in Ghanaian with stage-2 hypertension.
    Bello-Rodriguez BM; Sanchez-Cruz G; Delgado-Bustillo F; Asiama G
    Ghana Med J; 2013 Dec; 47(4):189-96. PubMed ID: 24669025
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Metabolic syndrome and cardiometabolic risk factors among indigenous Malaysians.
    Aghakhanian F; Wong C; Tan JSY; Yeo LF; Ramadas A; Edo J; Hoh BP; Khalid BAK; Phipps ME
    Public Health; 2019 Nov; 176():106-113. PubMed ID: 30509859
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Metabolic syndrome in men with low testosterone levels: relationship with cardiovascular risk factors and comorbidities and with erectile dysfunction.
    García-Cruz E; Leibar-Tamayo A; Romero J; Piqueras M; Luque P; Cardeñosa O; Alcaraz A
    J Sex Med; 2013 Oct; 10(10):2529-38. PubMed ID: 23898860
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Comparison of the Combined Obesity Indices to Predict Cardiovascular Diseases Risk Factors and Metabolic Syndrome in Northeast China.
    Tao Y; Yu J; Tao Y; Pang H; Yu Y; Yu Y; Jin L
    Int J Environ Res Public Health; 2016 Aug; 13(8):. PubMed ID: 27517940
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Application of three-dimensional body scanner: observation of prevalence of metabolic syndrome.
    Lin JD; Chiou WK; Weng HF; Fang JT; Liu TH
    Clin Nutr; 2004 Dec; 23(6):1313-23. PubMed ID: 15556253
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Relation between circulating oxidized-LDL and metabolic syndrome in children with obesity: the role of hypertriglyceridemic waist phenotype.
    Calcaterra V; De Giuseppe R; Biino G; Mantelli M; Marchini S; Bendotti G; Madè A; Avanzini MA; Montalbano C; Cossellu G; Larizza D; Cena H
    J Pediatr Endocrinol Metab; 2017 Nov; 30(12):1257-1263. PubMed ID: 29127769
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Adverse effects of coexistence of sarcopenia and metabolic syndrome in Japanese women.
    Sanada K; Iemitsu M; Murakami H; Gando Y; Kawano H; Kawakami R; Tabata I; Miyachi M
    Eur J Clin Nutr; 2012 Oct; 66(10):1093-8. PubMed ID: 22569087
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Metabolic syndrome, glucose tolerance categories and the cardiovascular risk in Spanish population.
    Martínez-Larrad MT; Corbatón-Anchuelo A; Fernández-Pérez C; Lazcano-Redondo Y; Escobar-Jiménez F; Serrano-Ríos M
    Diabetes Res Clin Pract; 2016 Apr; 114():23-31. PubMed ID: 27103365
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Metabolic Syndrome Components and Long-Term Incidence of Cardiovascular Disease in Eastern Mediterranean Region: A 13-Year Population-Based Cohort Study.
    Mansourian M; Babahajiani M; Jafari-Koshki T; Roohafza H; Sadeghi M; Sarrafzadegan N
    Metab Syndr Relat Disord; 2019 Sep; 17(7):362-366. PubMed ID: 31188051
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 20.